APA (7th ed.) Citation

Höger, P., Ries, M., Olivares-Rivera, A., Ersöz, H., Buschulte, K., Fähndrich, S., . . . Trudzinski, F. (2026). Advances in orphan drug development for alpha-1 antitrypsin deficiency: A 2025 update from the FDA and EMA. Therapeutic advances in respiratory disease, 20, . https://doi.org/10.1177/17534666251411227

Chicago Style (17th ed.) Citation

Höger, Philipp, Markus Ries, Arturo Olivares-Rivera, Hilal Ersöz, Katharina Buschulte, Sebastian Fähndrich, Konstantina Kontogianni, Felix Herth, and Franziska Trudzinski. "Advances in Orphan Drug Development for Alpha-1 Antitrypsin Deficiency: A 2025 Update from the FDA and EMA." Therapeutic Advances in Respiratory Disease 20 (2026). https://doi.org/10.1177/17534666251411227.

MLA (9th ed.) Citation

Höger, Philipp, et al. "Advances in Orphan Drug Development for Alpha-1 Antitrypsin Deficiency: A 2025 Update from the FDA and EMA." Therapeutic Advances in Respiratory Disease, vol. 20, 2026, https://doi.org/10.1177/17534666251411227.